Lisendo 880

Manufactured by Fujifilm

Sourced in Japan

The LISENDO 880 is a laboratory equipment product manufactured by Fujifilm. It is designed to perform various analytical and testing functions in a laboratory setting. The core function of the LISENDO 880 is to provide precise and reliable measurements and data analysis capabilities to support scientific research and product development.

Automatically generated - may contain errors

Lab products found in correlation

Acuson sc2000, by Siemens (1 mentions)

2 protocols using lisendo 880

Invasive Ventricular Relaxation Timing

Check if the same lab product or an alternative is used in the 5 most similar protocols

A total of 104 participants (mean age, 58 ± 21 years; 48 women) were referred to undergo IVRT measurements at our institution from January 2020 to November 2020. The participants were as follows: 42 healthy volunteers, 15 with abnormal electrocardiography (ECG), 14 individuals with hypertension, 9 with diabetes mellitus, 4 with dyslipidemia, 15 with ischemic heart disease, 3 with cardiomyopathy, 5 with valvular diseases, and 2 with hemodialysis. This study had been approved by clinical research ethics review committee in our hospital and a prospective study. Only participants could be obtained the consent for this study were included.
Transthoracic echocardiography (TTE) was performed using an ultrasound machine (LISENDO 880; FUJIFILM Healthcare Corporation, Tokyo, Japan). We used a cardiac microphone (MA-300; Fukuda Denshi, Tokyo, Japan). In all cases, the cardiac microphone was placed at the site of maximum IIs. All participants were in sinus rhythm and were hemodynamically stable during the examination.

Kimura N., Toide H., Kobayashi S., Tsujimoto E., Honda A., Sawada K., Higashi A., Koshikawa Y., Hana S, & Itabashi Y. (2023). Reliable measurement methods for the isovolumic relaxation time: comparisons of dual gate Doppler and seven other methods. Journal of Echocardiography, 22(1), 34-40.

+ Open protocol

+ Expand

Echocardiographic Estimation of Pulmonary Hypertension

Check if the same lab product or an alternative is used in the 5 most similar protocols

Transthoracic echocardiography and tissue Doppler echocardiography were performed with ACUSON SC2000 (Siemens Healthcare, Tokyo, Japan) and LISENDO 880 (FUJIFILM, Tokyo, Japan). TRPG is an index calculated with the Bernoulli equation from TRV (tricuspid regurgitation velocity) values, and its formula is as follows: TRPG (mmHg) = 4 × (TRV(m/sec)²). TRPG value correlates with the right ventricular systolic pressure and to the estimated pulmonary artery systolic pressure in the absence of obvious outflow tract stenosis. In practice, it is known from previous reports that a mean PAP of 25 mmHg is comparable to a TRPG of 36 mmHg.¹⁴ The European Society of Cardiology guidelines use TRV values in the practice of pulmonary hypertension, and TRPG ≥33.6 mmHg corresponds to TRV ≥2.9 m/s for possible intermediate pulmonary hypertension. Since this study was designed to narrow down the candidate of patients who might have PoPH, the cutoff value of TRPG was set at 30 mmHg for the surrogate endpoint of possible pulmonary artery hypertension.

Yamashita K., Kurosaki M., Nakanishi H., Tanaka Y., Ishido S., Inada K., Kirino S., Hayakawa Y., Matsumoto H., Nobusawa T., Kakegawa T., Higuchi M., Takaura K., Tanaka S., Maeyashiki C., Kaneko S., Tamaki N., Yasui Y., Tsuchiya K., Takahashi Y., Miyazaki R., Ashikaga T., Enomoto N, & Izumi N. (2022). Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension. JGH Open: An Open Access Journal of Gastroenterology and Hepatology, 6(11), 774-781.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!